BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

COVID-19

4 posts

Coronavirus infection (COVID-19) is an illness caused by the SARS-CoV-2 virus. It is an infectious disease.

According to the World Health Organization, the majority of people who become infected with the COVID-19 virus will experience respiratory illness on mild to moderate scales with recovery that does not require special treatment. However, some who contract the virus will become seriously ill and require medical attention.

Older persons and those who have underlying medical issues such as cardiovascular disease, diabetes, chronic respiratory illness, or cancer are more likely to become seriously ill. COVID-19 can affect anybody at any age and cause serious illness or death regardless of age.

The greatest way to prevent and slow the spread of the virus is to be well-informed about it and how it spreads. Wash your hands or use an alcohol-based rub frequently, avoid touching others, and maintain at least 1 meter of distance from others to prevent infection. When it’s your turn, be vaccinated, and follow local recommendations.

The virus is carried in tiny liquid particles when people cough, sneeze, talk, sing, or breathe. The particles in the air vary from those that are big respiratory droplets to smaller aerosols. It’s crucial to follow respiratory etiquette, such as by coughing into a flexed elbow, and staying home and isolating oneself until you feel well again.

Biotech NewsNovavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts

  • BioTech Health X
  • May 10, 2024
In a landmark agreement, Novavax (NASDAQ: NVAX) has partnered with French pharmaceutical giant Sanofi to escalate the fight…
0 Shares
0
0
0
0
0
0
0
SyneuRx CEO Interview Dr Emil Tsai BioTech Health X

BioTech CEO InterviewsSyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections

  • BioTech Health X
  • September 2, 2022
Our BioTech Health X CEO Series continues with an exclusive interview with Dr. Emil Tsai of SyneuRx. Today…
0 Shares
0
0
0
0
0
0
0
Ministry of Food Drug Safety of South Korea Moderna COVID 19 Vaccine

Biotech NewsModerna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization

  • BioTech Health X
  • May 21, 2021
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
0 Shares
0
0
0
0
0
0
0
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In

Biotech NewsCOVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In

  • BioTech Health X
  • May 13, 2021
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Aclaris (ACRS) Advances Groundbreaking Therapies for Autoimmune Diseases
  • Pulmonx (LUNG) Reports $68.7M Revenue with 28% Growth and COPD Innovations
  • UroGen (URGN) Posts $25.2M Q3 Revenue, Targets $5B Market with UGN-102 Launch
  • ABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study
  • Rigel (RIGL)’s Q3 2024 Revenue Hits $55.3M
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • November 20, 2024
    Aclaris (ACRS) Advances Groundbreaking Therapies for Autoimmune Diseases
    • November 17, 2024
    Pulmonx (LUNG) Reports $68.7M Revenue with 28% Growth and COPD Innovations
    Genentech Strategic Pivot The Closure of Its Cancer Immunology Unit
    • November 17, 2024
    UroGen (URGN) Posts $25.2M Q3 Revenue, Targets $5B Market with UGN-102 Launch
    • November 14, 2024
    ABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study
    Biogen Expands Immunology Portfolio with Strategic Acquisition
    • November 12, 2024
    Rigel (RIGL)’s Q3 2024 Revenue Hits $55.3M
Recent Posts
  • Lakeside Holding (LSH) Acquires Hupan Pharmaceutical to Enter China’s Medical Logistics Market
    • November 11, 2024
  • Autolus (AUTL) Reports Obe-cel Launch Progress and Strong Cash Position in Q2 2024
    • November 10, 2024
  • Biogen Expands Immunology Portfolio with Strategic Acquisition
    FDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer
    • November 8, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (79)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top